Literature DB >> 22858213

Reduced posterior corpus callosum area in suicidal and non-suicidal patients with bipolar disorder.

Fabiana Nery-Fernandes1, Marlos V Rocha, Andrea Jackowski, Giovanna Ladeia, Jose Luiz Guimarães, Lucas C Quarantini, Cesar A Araújo-Neto, Irismar R De Oliveira, Angela Miranda-Scippa.   

Abstract

BACKGROUND: Impulsivity is a characteristic of bipolar disorder (BD) that can contribute to the risk for suicidal behavior. Evidence suggests that gray and white matter abnormalities are linked with impulsivity, but little is known about the association between corpus callosum (CC) and impulsivity in BD. We examined the CC area and impulsivity in euthymic bipolar I patients, with and without lifetime history of suicide attempts, and in healthy controls.
METHODS: Nineteen bipolar patients with a suicide attempt history (BP-S), 21 bipolar patients without suicide attempt history (BP-NS), and 22 healthy controls (HC) underwent clinical assessment by the Structured Clinical Interview with the DSM-IV axis I (SCID-I), the Barratt Impulsiveness Scale (BIS-11), and MRI scan.
RESULTS: No differences were observed for any CC subregion between BP-S and BP-NS groups. There was a significant reduction in the genu (p=0.04) and isthmus areas (p=0.01), in bipolar patients compared with HC. In the BP-S group, the BIS-11 total (p=0.01), attention (p=0.001) and non-planning (p=0.02) impulsivity scores were significantly higher than in the BP-NS and HC groups. LIMITATIONS: These results cannot establish causality because of the cross-sectional nature of the study.
CONCLUSION: This report potentially provides evidence that a reduction in the CC area is present even in non-symptomatic bipolar patients, which may be evidence of a biological trait marker for BD. Furthermore, the study demonstrated that BP-S group had higher impulsivity even during euthymia, which points to a sustained association between lifetime history of suicide attempts and impulsivity in BD.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22858213     DOI: 10.1016/j.jad.2012.05.001

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  14 in total

1.  Differential impairment of interhemispheric transmission in bipolar disease.

Authors:  Vincenzo Florio; Silvia Savazzi; Andreas Conca; Carlo A Marzi
Journal:  Exp Brain Res       Date:  2013-07-16       Impact factor: 1.972

2.  Corpus callosum area in patients with bipolar disorder with and without psychotic features: an international multicentre study.

Authors:  Samuel Sarrazin; Marc-Antoine d'Albis; Colm McDonald; Julia Linke; Michèle Wessa; Mary Phillips; Marine Delavest; Louise Emsell; Amelia Versace; Jorge Almeida; Jean-François Mangin; Cyril Poupon; Katia Le Dudal; Claire Daban; Nora Hamdani; Marion Leboyer; Josselin Houenou
Journal:  J Psychiatry Neurosci       Date:  2015-09       Impact factor: 6.186

Review 3.  Epidemiology, neurobiology and pharmacological interventions related to suicide deaths and suicide attempts in bipolar disorder: Part I of a report of the International Society for Bipolar Disorders Task Force on Suicide in Bipolar Disorder.

Authors:  Ayal Schaffer; Erkki T Isometsä; Leonardo Tondo; Doris H Moreno; Mark Sinyor; Lars Vedel Kessing; Gustavo Turecki; Abraham Weizman; Jean-Michel Azorin; Kyooseob Ha; Catherine Reis; Frederick Cassidy; Tina Goldstein; Zoltán Rihmer; Annette Beautrais; Yuan-Hwa Chou; Nancy Diazgranados; Anthony J Levitt; Carlos A Zarate; Lakshmi Yatham
Journal:  Aust N Z J Psychiatry       Date:  2015-07-16       Impact factor: 5.744

4.  Rare case of glioblastoma multiforme located in posterior corpus callosum presenting with depressive symptoms and visual memory deficits.

Authors:  Hale Yapıcı-Eser; Aslıhan Onay; Özgür Öztop-Çakmak; Emrah Egemen; Ebru Nur Vanlı-Yavuz; İhsan Solaroğlu
Journal:  BMJ Case Rep       Date:  2016-12-15

5.  Preliminary examination of gray and white matter structure and longitudinal structural changes in frontal systems associated with future suicide attempts in adolescents and young adults with mood disorders.

Authors:  Elizabeth T Cox Lippard; Jennifer A Y Johnston; Linda Spencer; Susan Quatrano; Siyan Fan; Anjali Sankar; Judah Weathers; Brian Pittman; Maria A Oquendo; Hilary P Blumberg
Journal:  J Affect Disord       Date:  2018-11-28       Impact factor: 4.839

6.  Widespread white matter but focal gray matter alterations in depressed individuals with thoughts of death.

Authors:  Warren D Taylor; Brian Boyd; Douglas R McQuoid; Kamil Kudra; Ayman Saleh; James R MacFall
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2015-05-08       Impact factor: 5.067

7.  Normal Metabolic Levels in Prefrontal Cortex in Euthymic Bipolar I Patients with and without Suicide Attempts.

Authors:  Marlos Vasconcelos Rocha; Fabiana Nery-Fernandes; José Luiz Guimarães; Lucas de Castro Quarantini; Irismar Reis de Oliveira; Giovanna G Ladeia-Rocha; Andrea Parolin Jackowski; César de Araujo Neto; Ângela Miranda-Scippa
Journal:  Neural Plast       Date:  2015-05-13       Impact factor: 3.599

8.  Is there a neuroanatomical basis of the vulnerability to suicidal behavior? A coordinate-based meta-analysis of structural and functional MRI studies.

Authors:  Kees van Heeringen; Stijn Bijttebier; Stefanie Desmyter; Myriam Vervaet; Chris Baeken
Journal:  Front Hum Neurosci       Date:  2014-10-22       Impact factor: 3.169

9.  Neuroimaging Studies of Suicidal Behavior and Non-suicidal Self-Injury in Psychiatric Patients: A Systematic Review.

Authors:  Carmen Domínguez-Baleón; Luis F Gutiérrez-Mondragón; Adrián I Campos-González; Miguel E Rentería
Journal:  Front Psychiatry       Date:  2018-10-16       Impact factor: 4.157

Review 10.  Imaging suicidal thoughts and behaviors: a comprehensive review of 2 decades of neuroimaging studies.

Authors:  Lianne Schmaal; Anne-Laura van Harmelen; Vasiliki Chatzi; Elizabeth T C Lippard; Yara J Toenders; Lynnette A Averill; Carolyn M Mazure; Hilary P Blumberg
Journal:  Mol Psychiatry       Date:  2019-12-02       Impact factor: 13.437

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.